Filgotinib is a prescription medication used to treat adults with moderate to severe rheumatoid arthritis who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs). It belongs to a group of medications called Janus kinase (JAK) inhibitors, which work by blocking certain proteins in the body that are involved in inflammation. Filgotinib is taken orally in tablet form and is usually taken once daily. Common side effects include upper respiratory tract infections, headache, and nausea.
Filgotinib, also sold under the brand name Jyseleca, is a medication used to treat a specific condition: moderate to severe active rheumatoid arthritis (RA) in adults. Here's a closer look at its key features:
Therapeutic Class: Filgotinib belongs to a drug class called Janus kinase (JAK) inhibitors. JAK enzymes are involved in the inflammatory response of the body. By inhibiting these enzymes, filgotinib helps reduce inflammation associated with RA.
How it Works: There are several JAK enzymes, but filgotinib is considered selective for JAK1, meaning it primarily targets this specific enzyme subtype. This targeted action is thought to contribute to its effectiveness in managing RA.
Applications in RA:
- Moderate to Severe Cases: Filgotinib is typically used for adults with moderate to severe RA who haven't responded adequately to, or cannot tolerate, other medications called disease-modifying antirheumatic drugs (DMARDs). These are often the first-line treatment for RA.
- Monotherapy or Combination: Filgotinib can be used alone (monotherapy) or in combination with methotrexate, another medication used in RA treatment.
Benefits:
- Reduced Inflammation: Filgotinib helps reduce pain, swelling, stiffness, and joint damage associated with RA.
- Improved Function: By controlling inflammation, filgotinib can improve a patient's ability to perform daily activities.
Important Considerations:
- Not a Cure: Filgotinib doesn't cure RA, but it can help manage the symptoms and slow disease progression.
- Potential Side Effects: Common side effects include nausea, upper respiratory tract infections, urinary tract infections, and dizziness. More serious side effects, though uncommon, are also possible.
- Monitoring Needed: Regular blood tests are required while taking filgotinib to monitor for potential side effects.
Overall:
Filgotinib provides a treatment option for adults with moderate to severe RA who haven't responded well to other medications. It helps manage inflammation and improve joint function. However, it's crucial to be aware of potential side effects and undergo regular monitoring by a healthcare professional.